Novel animal model of lymph node metastasis by intrauterine inoculation of the actively metastatic subline PL3 separated from rat Walker 256 tumor cells

Invasion and Metastasis

Volumn 17, Issue 3, 1998, Pages 149-157

  Hashii, Koji ^a   Tohya, Kazuo ^b   Kimura, Michio ^b   Tateyama, Ichiro ^b   Mori, Takahide ^a   Kadota, Eiji ^c   Hashimoto, Shigeo ^b   Tomura, Takamori ^b  

^a KYOTO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c Kishiwada City Hospital   (Japan)

Author keywords

Endometrial invasion; Lymph node metastasis; Rat; Walker 256 cell

Indexed keywords

INTEGRIN;

ANIMAL MODEL; ARTICLE; CANCER CELL; CELL FUNCTION; ELECTRON MICROSCOPY; ENDOMETRIUM; FEMALE; LYMPH NODE METASTASIS; LYMPH VESSEL; METASTASIS; MYOMETRIUM; NONHUMAN; PARENCHYMA; RAT; UTERUS CAVITY; WALKER CARCINOMA;

ANIMALS; CARCINOMA 256, WALKER; CULTURE MEDIA; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HYDROGEN-ION CONCENTRATION; LYMPHATIC METASTASIS; NEOPLASM TRANSPLANTATION; RATS; UTERINE NEOPLASMS;

EID: 0344625421     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hanson MB, Van Nagell JR Jr, Powell DE, Donaldson ES, Gallion H, Merhige M, Pavlik EJ: The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 1985;55:1753-1757.
2. Lampe B, Kurzl R, Hantschmann P: Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma. Cancer 1994; 74:2502-2508.
3. Carr I, Pettigrew N, Weinerman B: Lymphatic metastasis and its treatment. Cancer Treat Rev 1987;14:53-64.
4. 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell 1994;77:335-374.
5. Kato Y, Nakayama Y, Umeda M, Miyazaki K: Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J Biol Chem 1992;267:11424-11430.
6. Carr J, Carr I, Dreher B, Betts K: Lymphatic metastasis: Invasion of lymphatic vessels and efflux of tumour cells in the afferent popliteal lymph as seen in the Walker rat carcinoma. J Pathol 1980;132:287-305.
7. Harima K, Harima Y, Hasegawa T, Tanaka Y: Transcatheter arterial embolization as a method of cisplatin-retention enhancement on the VX2 tumor uterus transplants. Cardiovasc Intervent Radiol 1995;18: 30-34.
8. Shaughnessy SG, Lafrenie RM, Buchanan MR, Podor TJ, Orr FW: Endothelial cell damage by Walker carcinosarcoma cells is dependent on vitronectin receptor-mediated tumor cell adhesion. Am J Pathol 1991;138:1535-1543.
9. Shaughnessy SG, Whaley M, Lafrenie RM, Orr FW: Walker 256 tumor cell degradation of extracellular matrices involves a latent gelatinase activated by reactive oxygen species. Arch Biochem Biophys 1993;304:314-321.
10. Kurman RJ, Norris HJ: Endometrial carcinoma; in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract. Berlin, Springer, 1987, pp 338-372.
11. Boving BG, Larsen JF: Implantation; in Hafez ESE, Evans TN (eds): Human Reproduction, Conception and Contraception. Hagerstown, Harper and Row, 1973, pp 133-156.
12. Griffioen AW, Horst E, Heider KH, Wielenga VJM, Adolf GR, Herrlich P, Pals ST: Expression of CD44 splice variants during lymphocyte activation and tumor progression. Cell Adhes Commun 1994;2:195-200.
13. Head JR, Seeling LL Jr: Lymphatic vessels in the uterine endometrium of virgin rats. J Reprod Immunol 1984;6:157-166.
14. Szakal AK, Holmes KL, Tew JG: Transport of immune complexes from the subcapsular sinus to lymph node follicles on the surface of nonphagocytic cells, including cells with dendritic morphology. J Immunol 1983;131:1714-1727.
15. Zoller M, Herrlich P, Ponta H: Metastatic tumor cells mimic lymphocytes. Pathol Biol 1994;42:31-32.